Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively "DAWA"


Phase 2/3 Results

Summary of Purpose

DAWA is a phase 2, prospective, open-label, randomized, pilot study. The main variable to be observed in this study is intracardiac thrombus. There are no formal primary or secondary clinical efficacy or safety outcomes because it is a pilot study. Trial Stopped: because a significant decrease of viable candidates for the study.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 September 2015.

1 Aug 2013 28 May 2013 1 Sep 2014 1 Oct 2014 1 Sep 2015 24 Jun 2015
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment